Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia
NCT05804734
·
clinicaltrials.gov ↗
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Hemophilia A
Hemophilia B
Anticoagulant-induced Bleeding
Interventions
DRUG:
Vitamin K Antagonist - Drug
Sponsor
Groupe Maladies hémorragiques de Bretagne